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Vitelliform macular dystrophies (VMD) are inherited retinal dystrophies characterized by yellow, round deposits visible upon fundus
examination and encountered in individuals with juvenile Best macular dystrophy (BMD) or adult-onset vitelliformmacular dystrophy
(AVMD). Although many BMD and some AVMD cases harbor mutations in BEST1 or PRPH2, the underlying genetic cause remains
unknown for many affected individuals. In a large family with autosomal-dominant VMD, genemapping and whole-exome sequencing
led to the identification of a c.713T>G (p.Leu238Arg) IMPG1mutation, which was subsequently found in two other families with auto-
somal-dominant VMD and the same phenotype. IMPG1 encodes the SPACR protein, a component of the rod and cone photoreceptor
extracellular matrix domains. Structural modeling indicates that the p.Leu238Arg substitution destabilizes the conserved SEA1 domain
of SPACR. Screening of 144 probands who had various forms of macular dystrophy revealed three other IMPG1mutations. Two individ-
uals from one family affected by autosomal-recessive VMD were homozygous for the splice-site mutation c.807þ1G>T, and two from
another family were compound heterozygous for the mutations c.461T>C (p.Leu154Pro) and c.1519C>T (p.Arg507*). Most cases had a
normal or moderately decreased electrooculogram Arden ratio. We conclude that IMPG1 mutations cause both autosomal-dominant
and -recessive forms of VMD, thus indicating that impairment of the interphotoreceptor matrix might be a general cause of VMD.Macular dystrophies are inherited retinal dystrophies in
which various forms of deposits, pigmentary changes,
and atrophic lesions are observed in the macula lutea,
the cone-rich region of the human central retina.
Mutations in several genes, expressed in either the
photoreceptor rods and cones (ABCA4 [MIM 601691],
ELOVL4 [MIM 605512], PRPH2 [MIM 179605], PROM1
[MIM 604365]) or in the retinal pigment epithelium
(BEST1 [MIM 607854], CDH3 [MIM 114021], TIMP3
[MIM 188826]), the photoreceptor supporting tissue, are
associated with inherited macular dystrophies.
Vitelliformmacular dystrophies (VMDs) form a subset of
macular dystrophies characterized by yellow, round de-
posits usually at the center of the macula and containing
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The Americanby autofluorescence imaging of the fundus.1 Best macular
dystrophy (BMD [MIM 153700]) is a juvenile form of
VMD inherited as an autosomal-dominant trait;2 it leads
to a loss of visual acuity and in many cases features a
characteristic decrease in the Arden ratio obtained from
the electrooculogram. Many families affected by BMD
harbor a heterozygous mutation in BEST1,3,4 which is
specifically expressed in the retinal pigment epithelium
(RPE).5 In addition to BMD, there are cases of adult-onset
vitelliform macular dystrophy (AVMD [MIM 608161]),
which are frequently simplex and feature a small vitelli-
form disc on the fovea, a moderate loss of visual acuity,
and a normal Arden ratio. In AVMD-affected families
showing autosomal-dominant inheritance, mutations in
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Figure 1. Pedigrees of the Families Affected by Autosomal-Dominant Vitelliform Macular Dystrophy
(A–C) Pedigrees, alleles of the microsatellite markers surrounding IMPG1, and the IMPG1 c.713T>G (p.Leu238Arg) mutation are shown
in families MTP327 (A), MTP1290 (B), and MD0531 (C). The haplotype common to the three families is shown in black.
(D) Electropherograms showing the normal control sequence and the affected sequence (from individual IV:2 of family MTP327)
surrounding the c.713T>G mutation.cases of AVMD and some cases of BMD do not harbor
mutations in either BEST1 or PRPH2.8 The involvement
of both genes was also excluded from a form of auto-
somal-dominant atypical VMD described in one family
(VMD1 [MIM 153840]).9 Therefore, a subset of VMD-
affected individuals must harbor mutations in other genes.
Members of a large French family (MTP327) were iden-
tified as having autosomal-dominant VMD. The disease
was assessed with visual-acuity testing, funduscopy, and
autofluorescence imaging. A full-fields electroretinogram
(ERG) was recorded with a ganzfeld apparatus (Metrovi-
sion, Pe´renchies, France) with a bipolar contact lens
electrode on maximally dilated pupils according to the
international ISCEV protocol. Dim blue stimulation after
20 min of dark adaptation was used for eliciting rod
responses, and 30 Hz flicker stimulation after 10 min of
light adaptation was used for eliciting cone responses.
Electrooculography (EOG) was also performed, and the
Arden ratio, defined as the ratio of the amplitude of the
light peak over that of the dark trough, was calculated
(normal value R 1.80). There were eight affected individ-
uals in six generations examined (Figure 1A). The age of572 The American Journal of Human Genetics 93, 571–578, Septembonset ranged from 20 to 45 years, and the mean visual
acuity was 20/30 (Table 1). Six of eight individuals had a
single subfoveal vitelliform lesion, and two individuals,
V:2 and V:5, had several small vitelliform deposits in
both eyes (Figure 2). In most individuals, the ERG rod
responses were above the lower limit (except IV:4, who
had moderately decreased responses), and the cone
responses were either normal or moderately decreased.
All individuals except IV:6 had a normal or a slightly
decreased (V:5) EOG Arden ratio (Table 1). Informed and
written consent consistent with the tenets of the Declara-
tion of Helsinki was obtained for all participating indi-
viduals. IRB approval was obtained for this study from
the Department of Ophthalmology of the Hospital of
Montpellier. Direct Sanger sequencing of the coding exons
and adjacent intronic sequences of BEST1 and PRPH2
(primer pairs and PCR conditions are available on request)
as well as QMPSF (quantitativemultiplex PCR of short fluo-
rescent fragments) and MLPA (multiplex ligation-depen-
dent probe amplification) analysis aimed at detecting
large genomic rearrangements did not detect any disease-
causing variant. To localize the gene defect responsibleer 5, 2013
Table 1. Summary of Clinical Data
Sex, Age
Visual Acuity
(right eye; left eye)
EOG Arden Ratio
(Right Eye; Left Eye)
ERG (Dim Blue Light; 30 Hz Flickers
Right Eye Left Eye
MTP327
IV:2 F, 63 20/200; 20/60 2.49; 2.82 217; 98 208; 97
IV:4 M, 63 20/50; 30/50 2.11; 2.27 132; 67 104; 62
IV:6 M, 56 20/400; CF 1.25; 1.34 205; 42 227; 49
V:2 F, 36 20/20; 20/20 ND ND
V:3 F, 31 20/200; 20/40 2.44; 2.62 ND
V:4 M, 28 20/20; 20/25 1.94; 1.95 ND
V:5 M, 37 20/20; 20/20 1.71; 1.54 274; 70 233; 61
V:6 F, 21 20/60; 20/20 2.20; 2.01 258; 51 243; 48
MTP1290
III:4 M, 64 20/40; 20/30 1.66; 1.73 333; 83 319; 72
III:5 M, 62 20/20; 20/20 2.44; 2.14 292; 61 262; 78
MD0531
III:1 F, 65 40/200; 20/200 2.91; 2.85 427; 105 409; 101
III:5 F, 55 20/30; 25/30 2.25; 2.35 385; 88 357; 72
III:8 M, 49 40/200; 20/50 2.31; 2.61 ND
NAL69
II:2 F, 46 20/30; 25/30 1.48; 1.64 normal sc and ph ERG
II:4 F, 43 20/20; 20/20 1.58; 1.68 normal sc ERG, slightly
decreased ph ERG
NA1863
II:1 M, 34 20/22; 20/22 1.53; 1.61 decreased sc and ph ERG
II:2 F, 29 20/33; 20/20 1.67; 2.41 decreased sc and ph ERG
NAX1
II:2 F, 40 20/60; 20/40 2.32; 2.55 121; 75 146; 81
Abbreviations are as follows: CF, counting fingers; ND, not done; EOG, electrooculography; ERG, full-field electroretinography; M, male; F, female; ERG values for
dim blue stimulation are amplitudes of the b wave (normal > 150 mV) and for 30 Hz flickers the peak-to-peak amplitude (normal > 70 mV); sc, scotopic; and ph,
photopic.for VMD, we performed a genome-wide scan of the 15
living individuals of the family at the Centre National
de Ge´notypage (CNG, Evry, France) by using a 250K Nsp
Array (Affymetrix, Santa Clara, CA). The results were ana-
lyzed with TASE, a custom software program that compares
every SNP between each individual in the family,10 and
showed that affected persons shared a common 95.2 Mb
haplotype in chromosomal region 6p12.1–q24.3, between
the SNPs rs1076701 and rs6910680 (Figure 3). We
confirmed the linkage at this locus with microsatellite
markers; the maximum LOD score (calculated with Super-
link-online) was 3.02 for D6S1622 on 6q13 (Figure 1). This
95.2 Mb region contains 705 genes. Within this region are
ELOVL4, which causes dominant macular Stargardt-like
dystrophy, and the MCDR1 [MIM 136550] locus known
to cause North Carolina macular dystrophy (Figure 3).The AmericanAll exons and flanking intron regions of ELOVL4 were
sequenced, but no mutation was found. The relevant
gene within the MCDR1 locus remains unknown and, in
addition, the phenotype of the MTP327 family differs
from that of North Carolina macular dystrophy.
To identify the pathogenic mutation, we performed
whole-exome sequencing (WES) of seven affected individ-
uals of family MTP327 (individuals IV:2, IV:4, IV:6, V:3,
V:4, V:5, and V:6) by using SureSelect Human All Exon
Kits Version 3 in-solution enrichment methodology
(Agilent, Santa Clara, CA). After excluding the common
variants listed in the dbSNP 131, we filtered the 1,170
single-nucleotide variants (SNVs) and 307 indels on chro-
mosomal region 6p12.1–q24.3 to keep only those present
in coding and splice-site regions in the seven affected
heterozygous individuals, reducing the number of variantsJournal of Human Genetics 93, 571–578, September 5, 2013 573
A, MTP 327 IV:2 B, MTP 327 V:2 C, MTP 1290 III:4 D, MTP 1290 III:4
E, MD 0531 III:1 F, MD 0531 III:8 G, NAL 69 II:4 H, NAL 69 II:4
I, NA 1863 II:1 J, NA 1863 II:2 K, NA 1863 I:1 L, NA 1863 I:2
Figure 2. Fundus Pictures Showing the Vitelliform Macular Dystrophy Phenotypes Caused by IMPG1 Mutations
Codes for family names and member numbers refer to the family trees from Figures 1 and 4. Color pictures are fundus photographs,
and black and white pictures (B, D, and H) are autofluorescence fundus imaging. Among the three families with the heterozygous, domi-
nantly inherited missense change p.Leu238Arg, in family MTP327 (A) a macular, round vitelliform deposit containing highly autofluor-
escent material is found (B), whereas in family MTP1290 multifocal vitelliform deposits are encountered (C) also with autofluorescent
material (D), and in family MD0531macular (E) and multifocal (F) vitelliform deposits are found in distinct individuals. In the two fam-
ilies with recessive inheritance, a similar macular vitelliform deposit was found. In family NAL69, a small round macular deposit (G,
insert: retinal scan showing the foveal dome-shaping accumulation of vitelliform material), which was autofluorescent (H), was seen.
In family NA1863 there were additional multifocal vitelliform deposits in the two affected individuals (I and J); the heterozygous asymp-
tomatic parents showed only tiny vitelliform spots outside the macula (K and L).to only six SNVs and one indel (Table S1). Three of the
missense SNVs were found in the EVS database with a fre-
quencyR 6/13,006, and the two other missense SNVs and
the indel belonged to genes with wide tissue expression.
We therefore retained a heterozygous missense variant,
c.713T>G in exon 7 of IMPG1 (MIM 602870, RefSeq
accession number NM_001563.2), that caused a leucine-
to-arginine substitution (p.Leu238Arg) at codon 238 in
the encoded protein SPACR, preferentially expressed in
the eye (Figure 1D). This variant was not found in public
human SNP databases and was not detected in 114 control
chromosomes from unaffected ethnically matched indi-
viduals. The mutation cosegregated with the disease
phenotype in all affected members and was absent in all
unaffected members (Figure 1A).
We then sequenced exon 7 of IMPG1 in a series of 251
unrelated probands with VMD and various other forms
of macular dystrophy. In two other families affected by
autosomal-dominant VMD (family MTP1290 from France
and familyMD0531 from Spain), we found that all affected
individuals were heterozygous for the same c.713T>G
change, whereas nonaffected individuals did not harbor
the mutation (Figure 1). In both of these families, the574 The American Journal of Human Genetics 93, 571–578, SeptembERG responses were normal, and all individuals had a
normal or slightly decreased (III:4 of family MTP1290)
Arden ratio (Table 1). To test the origin of the c.713T>G
change in the three families (MTP327, MTP1290, and
MD0531), we genotyped the microsatellite markers
D6S1622, D6S456, D6S1589, and D6S251, which spanned
the 7.2 Mb surrounding IMPG1. We found that all affected
members of the three families shared the same alleles of
the two markers D6S456 (76,107,334 nt) and D6S1589
(78,456,489 nt) flanking IMPG1, suggesting that the three
families could be distantly related (Figure 1). In addition,
among the seven candidate genes resulting from the
WES, only IMPG1 was located in this shared region, thus
definitively assigning IMPG1 to VMD in these families.
Multiple-amino-acid sequence alignment of SPACR
orthologs showed the conservation of the leucine at
position 238 in some mammals and a substitution to
phenylalanine in other orthologs (Figure S1A). The sub-
stitution p.Leu238Arg was predicted to be damaging by
PolyPhen2, SIFT, and align-GVGD programs. Sequence
comparison indicated that the Leu238 residue, in agree-
ment with the presence of a conserved hydrophobic resi-
due (Leu or Phe) at that position in known orthologs, iser 5, 2013
rs1076701 rs6910680
Chr. 6
53.8 Mb 149 Mb
ELOVL4 MCDR1IMPG1
IMPG1
c.1824+1G>A c.1212+2T>C
Mapped locus
A
B
c.807+1G>T
SEA1 SEA2
SPACR
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D6S456 D6S1589 Figure 3. Chromosomal Localization
of IMPG1, Protein-Domain Organization
of SPACR, and Position of Detected
Mutations
(A) The 95.2 Mb mapped disease locus
in chromosomal region 6p12.1–q24.3 for
family MTP327 is located between the
SNPs rs1076701 and rs6910680. IMPG1,
ELOVL4, and MCDR1 within the region
and PRPH2/RDS outside the region are
indicated. The position of D6S456 and
D6S1589 markers shared by the three fam-
ilies with the p.Leu238Arg substitution
is shown between dotted lines.
(B and C) Schematic representation of the
exon-intron structure of IMPG1. Shown
are (B) the location of the splice-site
mutations found in this study and (C) the
domain structure of its encoded SPACR
protein, including the signal peptide,
the N-terminal SEA1 and C-terminal
SEA2 domains, the mucin-like domain
(dotted line), the autoproteolytic site (*),
and the EGF-like domain. The missense
and nonsense changes found in this
study are indicated, as is the previously
described change p.Leu579Pro in the
BCAMD condition.buried in the hydrophobic core of the N-terminal SEA
domain (SEA1) of SPACR, the IMPG1 protein product. A
model of the N-terminal SEA1 domain was built with
ViTO software11 and the NMR structure of PDB1IVZ12
served as a template. Substitution of the hydrophobic
nonpolar Leu238 for the positively charged arginine would
destabilize the protein because there are many hydro-
phobic residues in its environment (Figure S2). Indeed,
Arg238 cannot move toward a more polar environment,
thus modifying the SEA1 domain of SPACR.
To further characterize the effect of the p.Leu238Arg
substitutiononSPACR,weperformed immunoblot analysis
and immunofluorescence analysis onCos7 cells transiently
transfected with pRK5 fused in-frame with wild-type or
p.Leu238Arg mutant SPACR. By immunoblotting with a
rabbit anti-SPACR polyclonal antibody,13 we found that
both wild-type and mutant proteins migrated at the
predictedmolecular weight of 147 kDa (Figure S3A). By per-
forming immunofluorescence analysis with the same anti-
body and using a secondary donkey anti-rabbit antibody
(Alexa Fluor 488-conjugated, Invitrogen, Courtaboeuf,
France), we found that both wild-type andmutant proteins
localized to the cytoplasm with the same pattern (Figures
S3B and S3C), suggesting that the pathogenic effect of the
p.Leu238Arg substitution does not involve subcellular traf-
ficking or severe protein unfolding.
We then sequenced the 17 exons and flanking intronic
regions of IMPG1 in 144 probands, a subset of the 251
unrelated probands who had VMD and various forms of
macular dystrophy and who were used for exon 7
screening. In the French family NAL69, we found thatThe Americanthe proband (II:4) and his affected sister (II:2) were com-
pound heterozygous for the paternal c.1519C>T mutation
in exon 13, leading to the nonsense change p.Arg507*, and
for the maternal c.461T>C mutation in exon 3, leading
to the missense change p.Leu154Pro (Figure 4A). The
p.Arg507* change was found in the EVS database at a
very low frequency (1/13,006 alleles). The p.Leu154Pro
substitutionwas not found in public human SNP databases
and is predicted to be damaging by PolyPhen2, SIFT, and
align-GVGD programs. The Leu154 residue is conserved
in mammals and is replaced by other hydrophobic
aliphatic amino acids in birds and fish, in which an
isoleucine or a valine, respectively, is found at this posi-
tion (Figure S1A). In the consanguineous Italian family
NA1863, we found that the affected brother II:1 and the
affected sister II:2 were homozygous for the splice-site
mutation c.807þ1G>T in intron 7, which was absent
from the human SNP databases, whereas the asymptom-
atic parents were each heterozygous for the mutation
(Figure 4A). In affected individuals of families NAL69 and
NA1863, the EOG Arden ratio was moderately decreased
(Table 1). During fundus examination, some asymptom-
atic heterozygous carriers were found to have minor
changes. In family NAL69, although the daughter, III:2,
was normal, the son, III:1, showed a slight defect in the
line between the inner and outer segments in the nasal
parafovea of the left eye. In family NA1863, fundus exam-
ination showed that the parents had tiny extramacular
deposits (Figure 2). This suggests that the c.461T>C and
c.807þ1G>T changes could be sufficient to cause subclin-
ical retinal abnormalities and exert a mild pathogenicJournal of Human Genetics 93, 571–578, September 5, 2013 575
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Figure 4. Pedigrees of Families Showing Autosomal-Recessive Inheritance and of a Family with a Simplex Case of VitelliformMacular
Dystrophy
Families NAL69, NA1863, and NAX1, affected by vitelliform macular dystrophies. A double horizontal line indicates consanguinity
in family NA1863.effect at the heterozygous state. Yet, because the macular
vitelliform disc with decreased visual acuity (Table 1) was
present only in the individuals who were either compound
heterozygous (family NAL69) or homozygous (family
NA1863), it is likely that the disease in these two families
segregated as an autosomal-recessive trait.
An additional IMPG1 variant was found in a simplex
case of the French family NAX1. This female individual
had a small vitelliform disk and was heterozygous for
the splice-site mutation c.1824þ1G>A in intron 13; this
mutation was absent from the human SNP databases
(Figure 4A). No other mutation was found in this proband.
Her two unaffected sisters and her mother were also het-
erozygous for the mutation. However, the two unaffected
sisters shared a paternal allele different from the paternal
allele of the affected sister (Figure 4A), suggesting that
the proband could harbor an unidentified paternal muta-
tion located in the noncoding regions of IMPG1. An
incomplete penetrance or a mutation in a different gene
could also be considered.
The IMPG1 mutations found in the six families
(three with autosomal-dominant inheritance, two with
autosomal-recessive inheritance, and one simplex case)
described in this study caused a consistent VMD pheno-
type. A heterozygous missense change (p.Leu579Pro) in
SPACR was previously reported in individuals of one fam-
ily affected with a retinal disease called benign concentric
annular macular dystrophy (BCAMD [MIM 153870]).14
This autosomal-dominant condition was described only
in this family and features a perifoveal maculopathy.
Some family members progressively evolve with age to-
ward a retinitis pigmentosa (RP [MIM 268000]) phenotype
(night blindness and attenuated retinal arterioles) by the
fourth and fifth decades of life.15,16 None of the family
members with BCAMD showed vitelliform deposits. In576 The American Journal of Human Genetics 93, 571–578, Septembaddition, the six VMD families described herein did not
show any annular atrophy in the macular area, and aged
individuals did not show signs of RP. Therefore, the
IMPG1-linked VMD phenotype of our individuals is
different from that of BCAMD and thus represents a
different clinical form caused by IMPG1 mutations. Other
dominant or simplex cases of macular dystrophy that are
presumably similar to BCAMD have been reported, but
none of them have so far been linked to mutations in
IMPG1.17–22 In parallel, a screening of IMPG1 mutations
in other forms of inherited macular dystrophy23 or macu-
lar drusen24 failed to detect a mutation.
IMPG1 (interphotoreceptor matrix proteoglycan 1)
encodes SPACR, a 150 kDa sialoprotein associated with
photoreceptor cones and rods protein, a component of
the interphotoreceptor matrix located in the subretinal
space, in which photoreceptors and the RPE are in close
apposition.13,25 This 797 amino acid secreted glycoprotein
contains a central mucin-like domain and an EGF-like
domain in the C-terminal region (Figure 3). Both N- and
O-linked glycoconjugates are present, mainly bound in
the mucin-like domain, accounting for approximately
30% of the molecular mass.13 SPACR also contains two
SEA domains (after sea urchin sperm protein, enterokinase,
and agrin), a highly conserved structure composed of four
anti-parallel b sheets surrounded by a helices in an
O-linked glycosylation-rich environment.26 The SEA do-
mains are encountered in mucins, transmembrane serine
proteases, and dystroglycan. The C-terminal SEA2 domain
of SPACR contains the characteristic autoproteolytic
GSVIV sequence, a cleavage site shown in mucin 1
and dystroglycan to produce two polypeptides, which
remain tightly associated after proteolysis via the SEA
domain.27,28 The N-terminal SEA1 domain of SPACR does
not contain the cleavage site (Figure S1B). Apart fromer 5, 2013
cleavage, the roles of the SEA domains remain poorly
defined, although they might contribute to the adaptation
of the extracellular matrices to specific physical con-
straints. The substitution p.Leu238Arg, which was present
in the three families with the autosomal-dominant form
of VMD, is situated at the beginning of the N-terminal
SEA1 domain. We speculate that the p.Leu238Arg change
has a dominant-negative effect. However, we could not
detect any subcellular mislocalization, abnormal pro-
duction, or change in gel-migration properties of the
p.Leu238Arg altered protein (Figure S3), indicating that
c.713T>G is not a null mutation and that the pathogenic
effect of the mutant could be its abnormal behavior inside
the extracellular matrix. According to this hypothesis, null
mutations would lead to a full phenotype only in homo-
zygous or compound heterozygous states. This is indeed
what we have found here in the families with autosomal-
recessive inheritance, in which at least one allele carried
either a nonsense (family NAL69) or a presumed frameshift
(family NA1863) mutation. SPACR is highly homologous
to SPACRCAN (sialoprotein associated with photoreceptor
cone and rod proteoglycans),29 a 200 kDa protein encoded
by IMPG2 (interphotoreceptor matrix proteoglycan 2
[MIM 607056]) and also found in the interphotoreceptor
matrix. Mutations in IMPG2 cause RP, another form of
inherited retinal dystrophy with primary involvement of
the peripheral retina,30 highlighting the critical function
of the interphotoreceptor matrix in photoreceptor func-
tion and maintenance.31
The accumulation of vitelliform deposits in the retina is
encountered in conditions due to impaired metabolisms
of either photoreceptors or the RPE. The finding of
IMPG1- and SPACR-deficient cases introduces a third actor
in the causes of VMD; namely, this actor is the interphoto-
receptor matrix that joins together the photoreceptors
and the RPE. It will be of interest to further explore other
cases of VMD, unlinked to the above mentioned genes,
to test whether other components of the interphoto-
receptor matrix are involved in the VMDs.Supplemental Data
Supplemental Data include three figures and one table and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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